Literature DB >> 9741401

Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement.

M Filippi1, M A Rocca, G Comi.   

Abstract

We evaluated whether new multiple sclerosis (MS) lesions with variable durations of enhancement have different magnetization transfer ratios (MTR) at the time of their appearance. We scanned ten patients with relapsing-remitting MS every four weeks on four occasions. During each of the monthly sessions, we obtained dual echo, MT and T1-weighted scans. Five minutes after gadolinium-DTPA (Gd) injection, another T1-weighted scan was obtained. We measured the MTR of new enhancing lesions on co-registered quantitative MTR images. During the three-month follow up, 54 new enhancing lesions were seen with a mean MTR value of 33.6% (SD=7.8%). The mean MTR values were 35.3% (SD=7.0%) for lesions enhancing on only one scan and 29.3% (SD=8.6%) for those enhancing on at least two consecutive scans (P=0.01). These results suggest that enhancing lesions in MS have heterogeneous pathological substrates, which may be associated with different durations of the enhancing phase.

Entities:  

Mesh:

Year:  1998        PMID: 9741401     DOI: 10.1016/s0022-510x(98)00162-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis.

Authors:  M Siger-Zajdel; K Selmaj
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

Review 2.  Advanced MRI in multiple sclerosis: current status and future challenges.

Authors:  Robert J Fox; Erik Beall; Pallab Bhattacharyya; Jacqueline T Chen; Ken Sakaie
Journal:  Neurol Clin       Date:  2011-05       Impact factor: 3.806

Review 3.  Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.

Authors:  F Barkhof; M van Walderveen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

4.  The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosis.

Authors:  Deeya Gaindh; Neal Jeffries; Joan Ohayon; Nancy D Richert; Clelia Pellicano; Joseph A Frank; Henry McFarland; Francesca Bagnato
Journal:  Expert Opin Biol Ther       Date:  2008-12       Impact factor: 4.388

5.  Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.

Authors:  Daniel M Harrison; Navid Shiee; Pierre-Louis Bazin; Scott D Newsome; John N Ratchford; Dzung Pham; Peter A Calabresi; Daniel S Reich
Journal:  J Neurol       Date:  2012-08-12       Impact factor: 4.849

Review 6.  Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve.

Authors:  Massimo Filippi; Maria A Rocca
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

7.  Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.

Authors:  Sveinung Fjær; Lars Bø; Arvid Lundervold; Kjell-Morten Myhr; Tina Pavlin; Oivind Torkildsen; Stig Wergeland
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

8.  A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.

Authors:  A Gulati; F Bagnato; P Villoslada; N Velez de Mendizabal
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-04-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.